Skip to main content
Caplight Logo









NanoPalm

NanoPalm

Private
RiyadhHealthcare & Life Scienceshttps://nanopalm.ltd/

Last Round

Accelerator

Jun 19, 2025

Company Overview

NanoPalm is a biotechnology company that develops AI-designed patterned lipid nanoparticle (pLNP) delivery systems for gene and drug therapies.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical AI, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Infrastructure

Keywords

lipid nanoparticleLNPdrug deliveryAI drug discoverygene therapynanotechnologybiotech platformtherapeutic targetingdrug formulationprecision medicineAI-designed drugsdrug delivery techin silico drug designbiotech R&D

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

NanoPalm Comparables

Compare NanoPalm with similar companies based on industry and business-model similarity.

NanoPalm comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Mana.bio
88%
Liberate Bio
80%
Entos Pharmaceuticals
76%

NanoPalm Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorJun 19, 2025
AcceleratorApr 29, 2025

Key People

Founding team and executive leadership

Samar Alsudir

Co-Founder CTO

Founding Team

Ali H. AlHasan

Founder & CEO

Founding Team

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 2, 2025

    Grew 183% QoQ, from 6 to 17 employees.

  • Jul 29, 2025

    Grew 260% QoQ, from 5 to 18 employees.

NanoPalm Filings

Explore SEC and related filing metadata, where available.

NanoPalm filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about NanoPalm's valuation, stock price, and market status.

Is NanoPalm a public or private company?

NanoPalm is a private company.

What is the current stock price of NanoPalm?

NanoPalm is a private company with no public stock price. No recent secondary market data is available.

How much is NanoPalm worth (valuation)?

Valuation information for NanoPalm is not publicly available.

Can I buy NanoPalm stock?

NanoPalm shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was NanoPalm's last funding round?

NanoPalm's most recent funding round was Accelerator on June 19, 2025.

Who are the main investors in NanoPalm?

Investor information for NanoPalm is not publicly disclosed.

Will NanoPalm IPO soon?

No public IPO plans have been announced for NanoPalm.

How can I track NanoPalm secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor NanoPalm's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersRiyadh
Employee Range11
Year Founded2022
Last FundingJun 19, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?